We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Healthineers Introduces Autoanalyzer Assay for Monitoring Fentanyl Usage

By LabMedica International staff writers
Posted on 28 Jan 2020
A recently introduced diagnostic test for use on clinical chemistry autoanalyzers measures the levels of the opioid drug fentanyl and its primary metabolite norfentanyl.

Fentanyl is a synthetic opioid similar to morphine, prescribed for patients with chronic pain, post-operative pain, or treatment of breakthrough pain in cancer patients. More...
The [U.S.] Centers for Disease Control and Prevention has described fentanyl as being a synthetic opioid that is 50 times more potent than heroin and 100 times more potent than morphine.

There are two types of fentanyl: pharmaceutical fentanyl is prescribed to manage severe pain in cancer and surgical patients and end-of-life palliative care. Non-pharmaceutical fentanyl, or illicitly manufactured fentanyl, is often mixed with heroin and/or cocaine - with or without the user’s knowledge. Addictive cocktails incorporating illicitly manufactured fentanyl have evolved into the leading cause of drug overdose death.

When consumed, fentanyl is metabolized to norfentanyl and other metabolites. About 90% of the dose is excreted in urine as norfentanyl, while parent fentanyl accounts for less than 7%.

Siemens Healthineers (Erlangen, Germany) is now distributing the ARK Fentanyl Assay, which provides laboratories with a greater window to screen for fentanyl. The ARK Fentanyl Assay is 510(k) approved for diagnostic use by the [U.S.] Food and Drugs Administration and is CE Marked for use in Europe. The assay measures nanogram per milliliter levels of fentanyl and norfentanyl in 23 microliter urine samples and generates results after only seven minutes. It is available for automated clinical chemistry analyzers offered by Siemens Healthineers including on the Atellica Solution, Viva Systems, Dimension and Dimension Vista Systems.

“Fentanyl testing provides necessary clinical information for more effective patient care where a gap currently exists. Adding the ARK Fentanyl Assay to the Atellica Solution menu offers laboratories an extensive drugs-of-abuse testing menu which can be run efficiently on a single instrument,” said Dr. Deepak Nath, president of laboratory diagnostics at Siemens Healthineers. “It also empowers laboratories to help identify exposure and addiction in their communities, and aid clinicians in getting patients on the path to treatment.”

Related Links:
Siemens Healthineers


New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.